Traceable nanoparticles with mitochondria-targeting pyruvate-Cu induce cuproptosis for enhanced triple negative breast cancer therapy in mouse model

Key Points

• Enhanced therapy is achieved through traceable nanoparticles targeting mitochondria and inducing cuproptosis.
• The study reported effective delivery of pyruvate-Cu, leading to improved outcomes in triple negative breast cancer.
• Working with a mouse model, researchers utilized nanoparticles to enhance the biocompatibility of pyruvate-Cu.
• These findings indicate a promising avenue for new therapies, particularly in treating aggressive breast cancer types.